Form 4: Resmed CFO Receives Stock Grant
Insider Transaction (Form 4)
Aaron Bloomer, Chief Financial Officer of Resmed Inc, received 9,072 shares of common stock on August 14, 2026.
Summary
- Grant/award: acquired 9,072 ResMed Common Stock on August 14, 2026; holds 9,072 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Aaron Bloomer — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-14 | Grant/award | ResMed Common Stock | 9,072 | — | — | 9,072 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-14 | Grant/award (9,072 shares) |
Keywords
insider transaction, Form 4, RMD, RESMED INC, neutral, Aaron Bloomer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.